Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission ...

Allogene Therapeutics is a clinical-stage biotech developing allogeneic CAR T therapies for cancer and autoimmune diseases, with a focus on Cema-cel for LBCL. ALLO's advanced gene-editing platforms, ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies that could help oncology and immunology patients. Their pipeline has 3 interesting Phase 1 candidates for SLE, ...

The University of California, Irvine, which already has won much acclaim in stem cell research, recently received further confirmation of its status as an “alpha” in the industry. The California ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...

Alpha-lactalbumin, a multifunctional milk protein, has emerged as a key player in the field of tumour biology. In its native state, the protein is primarily involved in lactose synthesis; however, ...

Beta cells play a key role in the pathogenesis of both Type 1 and Type 2 diabetes. However, pancreatic islets also have alpha cells that produce the hormone glucagon, which acts to raise glucose blood ...